BARICORDI, Olavio
 Distribuzione geografica
Continente #
NA - Nord America 10.250
EU - Europa 5.474
AS - Asia 5.176
SA - Sud America 776
AF - Africa 72
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 7
Totale 21.765
Nazione #
US - Stati Uniti d'America 10.054
IT - Italia 2.524
CN - Cina 1.930
SG - Singapore 1.867
DE - Germania 805
UA - Ucraina 722
BR - Brasile 663
HK - Hong Kong 453
TR - Turchia 359
GB - Regno Unito 325
FI - Finlandia 292
VN - Vietnam 222
RU - Federazione Russa 180
SE - Svezia 131
FR - Francia 108
PL - Polonia 101
CA - Canada 96
NL - Olanda 89
IN - India 82
MX - Messico 81
AR - Argentina 42
AT - Austria 41
ID - Indonesia 40
BD - Bangladesh 36
JP - Giappone 36
ZA - Sudafrica 32
BE - Belgio 28
IQ - Iraq 26
ES - Italia 25
TH - Thailandia 25
EC - Ecuador 22
LT - Lituania 18
CH - Svizzera 17
CZ - Repubblica Ceca 16
UZ - Uzbekistan 15
IR - Iran 14
CO - Colombia 11
AE - Emirati Arabi Uniti 10
IE - Irlanda 10
VE - Venezuela 10
AU - Australia 8
EG - Egitto 8
MA - Marocco 8
MD - Moldavia 8
PY - Paraguay 8
RO - Romania 7
AZ - Azerbaigian 6
CL - Cile 6
IL - Israele 6
KZ - Kazakistan 6
PE - Perù 6
PK - Pakistan 6
SA - Arabia Saudita 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BB - Barbados 5
GR - Grecia 5
KE - Kenya 5
MY - Malesia 5
PH - Filippine 5
PT - Portogallo 5
CR - Costa Rica 4
KR - Corea 4
NG - Nigeria 4
TN - Tunisia 4
UY - Uruguay 4
BG - Bulgaria 3
BO - Bolivia 3
DK - Danimarca 3
DZ - Algeria 3
LB - Libano 3
NO - Norvegia 3
TT - Trinidad e Tobago 3
AL - Albania 2
BY - Bielorussia 2
EU - Europa 2
JM - Giamaica 2
JO - Giordania 2
KG - Kirghizistan 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
SI - Slovenia 2
AO - Angola 1
BH - Bahrain 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HU - Ungheria 1
LY - Libia 1
MN - Mongolia 1
MW - Malawi 1
NZ - Nuova Zelanda 1
QA - Qatar 1
RE - Reunion 1
RS - Serbia 1
RW - Ruanda 1
SN - Senegal 1
SY - Repubblica araba siriana 1
Totale 21.761
Città #
Singapore 1.039
Woodbridge 1.029
Fairfield 917
Ashburn 834
Chandler 732
Jacksonville 714
Houston 653
Beijing 549
Santa Clara 493
Hong Kong 450
Wilmington 377
Ann Arbor 375
Seattle 364
Hangzhou 326
Cambridge 292
Milan 277
New York 248
Rome 215
Munich 214
Izmir 213
Nanjing 189
Dallas 159
Los Angeles 156
Princeton 146
Boardman 125
Addison 99
Warsaw 93
Helsinki 88
Ho Chi Minh City 85
Shenyang 83
San Diego 78
São Paulo 74
Shanghai 69
Mexico City 65
Nanchang 62
Dearborn 61
Buffalo 60
Turku 57
Ferrara 54
Hebei 52
Bologna 48
The Dalles 48
Naples 46
Hefei 45
Turin 45
Bremen 41
Changsha 41
Tianjin 41
Toronto 41
Falkenstein 40
Hanoi 40
Verona 37
Vienna 35
Jiaxing 34
Falls Church 33
Tokyo 33
Bari 32
Brooklyn 32
London 31
Florence 30
Norwalk 30
San Mateo 30
Chennai 29
Denver 29
Montreal 28
Kunming 27
Mountain View 26
Palermo 26
Bangkok 25
Brussels 24
Chicago 24
Frankfurt am Main 24
Redwood City 23
Stockholm 23
Moscow 22
Augusta 21
Orem 21
Rio de Janeiro 20
Jinan 19
Johannesburg 18
Philadelphia 18
Guangzhou 17
Mumbai 17
Brescia 16
Padova 16
Zhengzhou 16
Boston 15
Orange 15
Ankara 14
Atlanta 14
Brasília 14
Carbonera 14
Modena 14
Ningbo 14
Washington 14
Amsterdam 13
Belo Horizonte 13
Manchester 13
Monmouth Junction 13
Phoenix 13
Totale 13.721
Nome #
Mutazione Q283P nel gene HFE in un eterozigote C282Y affetto da emocromatosi. 1.541
Associazione tra il polimorfismo c.1298A>C del gene MTHFR (Metilenetetraidrofolato Reduttasi) e l’artrite reumatoide 1.145
Human leukocyte antigen-G molecules are constitutively expressed by synovial fibroblasts and upmodulated in osteoarthritis 395
A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. 367
HLA-G molecules are constitutively expressed by synovial fibroblasts and up-modulated in osteoarthritis 276
Aberrant expression of HLA-DR antigen by bone marrow-derived mesenchymal stromal cells from patients affected by acute lymphoproliferative disorders 261
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells 216
HLA-G 14bp polymorphism regulates the methotrexate response in rheumatoid arthritis 214
Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma 206
Association between toluene diisocyanate-induced asthma and DQB1 markers: a possible role for aspartic acid at position 57 199
Clinical and MRI disease activity in multiple sclerosis are associated with reciprocal fluctuations in serum and cerebrospinal fluid levels of soluble HLA class I molecules 195
Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease 194
P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia 193
Enhanced P2X7 activity in human fibroblasts from diabetic patients: a possible pathogenetic mechanism for vascular damage in diabetes 192
An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes 189
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells from different sources. Evidence of discordant reactivity for various immunological markers 189
The antibiotic polymyxin B modulates P2X7 receptor function 187
Emerging topics and new perspectives on HLA-G 186
The antibiotic polymyxin B modulates P2X7 receptor function 183
Purinoceptor function in the immune system 183
Reduced production of anti-inflammatory soluble HLA-G molecules in styrene exposed workers 182
Analisi del polimorfismo IVS2+4T>C del gene HFE in soggetti con sovraccarico di ferro. 177
HLA-G expression is a fundamental prerequisite to pregnancy 177
Cotransplantation of mesenchymal cells and a higher relapse rate: a role for HLA-G molecules? 176
Increased sensitivity of DMD lymphoblastoid cell to low doses of X irradiation 174
Antigeni HLA e livelli sierici di HLA solubile nella malattia di Meniere 169
Antigenes sHLA-G et polypose naso-sinusienne. 169
A novel mutation of HFE explains the classical phenotype of hereditary hemochromatosis in a C282Y carrier 166
Defective production of soluble HLA-G molecules by peripheral blood monocytes in patients with asthma 164
Soluble HLA-G molecules in follicular fluid: a tool for oocyte selection in IVF? 164
Isolation of stem cell populations with trophic and immunoregulatory functions from human intestinal tissues: potential for cell therapy in inflammatory bowel disease 159
The c.1298A>C polymorphism in the Methylenetetrahydrofolate Reductase (MTHFR) gene is risk factor for Rheumatoid Arthritis 158
Role of protein kinase C in the phosphatidylserine-induced inhibition of DNA synthesis in blood mononuclear cells 157
Human leukocyte antigen-A, -B, -C and -DR alleles and soluble human leukocyte antigen class I serum level in Meniere's disease. 157
CYTOLYTIC P2X PURINOCEPTORS 156
Programmable interactions of functionalized single bioparticles in a dielectrophoresis-based microarray chip. 153
Basal production of soluble HLA-G molecules by peripheral blood monocytes in patients with diisocyanate-induced asthma. 153
Therapy modifies HLA-G secretion differently in Crohn's disease and ulcerative colitis patients. 153
Responses to extracellular ATP of lymphoblastoid cell lines from Duchenne muscular dystrophy patients 152
The HLA-G genotype is associated with IL-10 levels in activated PBMCs 152
Comment on "Experimental extracorporeal photopheresis inhibits the sensitization and effector phases of contact hypersensitivity via two mechanisms: Generation of IL-10 and induction of regulatory T cells" 148
Antigeni solubili di classe I classici e non classici (sHLA G) nei fluidi cerebrospinali della sclerosi multipla 143
Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings 143
Utilizzo delle MSCs nel controllo del rigetto dei trapianti 143
P2 purinoceptors in the immune system 142
Different production of soluble HLA-G antigens by peripheral blood mononuclear cells in Ulcerative Colitis and Crohn's disease: a non invasive diagnostic tools? 142
Allogeneic gene-modified tumour cells in metastatic kidney cancer. Report II 141
In vitro studies during long-term oral administration of specific transfer factor 141
Production of sHLA-G molecules by “in vitro” matured cumulus-oocyte complex 141
New insights into HLA-G and inflammatory diseases 141
Polymorphism in the 5' upstream regulatory and 3' untranslated regions of the HLA-G gene in relation to soluble HLA-G and IL-10 expression 141
Transfer factor in chronic mucocutaneous candidiasis 139
Allergic women have reduced sHLA-G plasma levels at delivery 139
Farmacogenetica dei taxani nel trattamento del carcinoma mammario: possibile ruolo nell’identificazione del rischio di tossicità. 139
A ryanodine receptor-like Ca2+ channel is expressed in nonexcitable cells 137
MICA exon 5 microsatellite typing by DNA heteroduplex analysis: a new polymorphism in the transmembrane region 137
Increased production of soluble HLA-G molecules in stimulated peripheral blood mononuclear cells following extracorporeal photopheresis. Is it a mechanism involved in the therapeutic effect of the procedure? 136
HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy 136
HLA B51 antigen associated with neutrophil hyper-reactivity 135
Increased proliferation rate of lymphoid cells transfected with the P2X7 ATP receptor 133
Allogeneic gene-modified tumour cells in metastatic kidney cancer. Preliminary report 132
Timing of Serum Soluble HLA-G Levels in Acute and Subacute Phases After Spontaneous Intracerebral Hemorrhage 132
Concentrazione di HLA-G solubile e interleuchina 10 nel plasma di pazienti psoriasici: possibile correlazione tra stato immunitario sistemico, trattamenti e malattia. 131
Multipotent stromal cells skew monocytes towards an anti-inflammatory function: A role for HLA-G molecules 131
Extarcellular ATP triggers IL-1beta release by activating the purinergic P2Z receptor of human macrophages 130
Soluble HLA-G and IL-10 production in occupational and nonoccupational asthma. 128
Soluble HLA-G and IL-10 production in occupational and nonoccupational asthma 127
Concentrazione di HLA-G solubile e interleuchina 10 nel plasma di pazienti psoriasici: possibile correlazione tra stato immunitario sistemico e malattia. 126
Soluble Human Leukocyte Antigen-G and Its Insertion/Deletion Polymorphism in Papillary Thyroid Carcinoma: Novel Potential Biomarkers of Disease? 125
Analisi dei genotipi ed aplotipi HFE nella popolazione Ferrarese 124
P2X7: a novel growth-stimulating receptor in B lymphoblastoid cells 124
Ruolo dell’HLA-G nel mantenimento del privilegio immune dell’occhio. 124
Effect of HLA-G gene polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. 122
Associazione tra HLA-G e Lupus Eritematoso Sistemico. 121
CSF levels and soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis 118
Frequenze genotipiche ed aplotipiche HFE nella popolazione della Provincia di Ferrara 117
Nucleotide receptor: an emerging family of regulatory molecules in blood cells 117
Anti HLA class I monoclonal antibody effect on PKC kinetics in PHA activated human peripheral blood mononuclear and E+ cells 116
Il ruolo del polimorfismo HLA-G 14bp nell'invecchiamento. 115
An anti-HLA class I monoclonal antibody alters the progression in the cell cycle of phytohemagglutinin-activated human T lymphocytes 115
In rheumatoid arthritis, a polymorphism in the HLA-G gene concurs in the clinical response to methotrexate treatment 113
Programmable binding of single microspheres to single target tumor cells using a dielectrophoresis (DEP) based “lab-on-a-chip” array. 113
CSF levels of soluble classical HLA-I and non-classical HLA-G molecules in relapsing-remitting multiple sclerosis and their association with CSF IL-10 concentrations and MRI findings. 112
Ruolo farmacogenetico del polimorfismo HLA-G 14bp nella risposta alla terapia con Methotrexate nell’artrite reumatoide. 111
Human leukocyyte antigen associations in occupational asthma induced by isocyanates 110
The c.1298A>C polymorphism in the methylenetetrahydrofolate reductase gene is associated with rheumatoid arthritis susceptibility in Italian patients 110
Inverse association between CSF levels of solubile HLA-G and Fas molecules in MS patients with no evidence of MRI disease activity. 109
HLA-G expression and regulation in early embryos 107
The possible role of HLA-G molecules in human oocyte/embryo secretome 107
Implication of immunosoppressive molecules during human oocyte maturation 106
Mouse dendritic cells express the P2X7 purinergic receptor: Characterization and possible participation in antigen presentation 106
Association between MTHFR C.1298A > C polymorphism in the methylene-tetrahydrofolate (MTHFR) gene and increased risk for rheumatoid arthritis 104
Potential role of soluble HLA-G molecules in multiple sclerosis 104
Presenza di molecole solubili HLA-G nel plasma da cordone ombelicale: un possibile marcatore di tolerogenicità? 102
Focus on the importance of soluble human leukocyte antigen G as a marker for embryo selection in assisted reproductive technology 101
Serological and molecular HLA typing in Italian Behcet's patients: significant association to B51-DR5-DQw3 haplotype 101
Antibody-antigen interactions in dielectrophoresis buffers for cell manipulation on dielectrophoresis-based Lab-on-chip devices. 101
Una nuova mutazione del gene HFE in un eterozigote C282Y con emocromatosi. 98
Ruolo biologico dell'HLA-G solubile nella gravidanza. 96
Non-classic sHLA class I in human oocyte culture medium 96
Totale 17.358
Categoria #
all - tutte 88.940
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 567
Totale 89.507


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021978 0 0 0 0 0 172 41 184 25 205 275 76
2021/20221.697 61 206 101 86 65 60 79 85 69 134 152 599
2022/20231.903 163 128 67 226 318 255 96 208 207 53 114 68
2023/20241.440 91 143 93 47 107 274 75 80 72 101 93 264
2024/20253.908 172 188 300 212 467 335 186 210 584 385 495 374
2025/20264.583 912 437 741 1.091 1.279 123 0 0 0 0 0 0
Totale 21.936